Glaxis Capital Management »

Vaneck Vectors Pharmaceutical etf shares owned by Glaxis Capital Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Glaxis Capital Management from 13F filings

Historical chart of Glaxis Capital Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Glaxis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Glaxis Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $272k 3.0k 90.70

More positions owned by Glaxis Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Dell Technologies CL C (DELL)
Aercap Holdings Nv SHS (AER)
Microsoft Corporation (MSFT)
Cohen & Steers Ltd Dur Pfd I (LDP)
Wal-Mart Stores (WMT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Pfd And Incm Sec (PFF)
Amazon (AMZN)
HEICO Corporation (HEI)
Principal Financial (PFG)
Metropcs Communications (TMUS)
Novo-nordisk A S Adr (NVO)
Arm Holdings Sponsored Adr (ARM)
Progressive Corporation (PGR)

View all positions for Glaxis Capital Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Northwestern Mutual Wealth Management Company
Miller Investment Management
Prime Capital Investment Advisors
Jpmorgan Chase & Co
Morgan Stanley
LPL Financial
Phoenix Holdings
Avestar Capital
J.Safra Asset Management
Susquehanna International
Citadel Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf